Recently, the National Health Commission proposed to establish a 15 minute walk nucleic acid sampling circle in large cities, and many cities also announced the normalization of nucleic acid testing, which has become a “rigid demand” to some extent.
Stimulated by this, concepts such as nucleic acid sampling kiosks and nucleic acid detection vehicles were born, and the share prices of many concept stock companies rose continuously last week. However, in the new week, relevant stocks continued to decline.
What is the actual sales situation of this business? Recently, Guangzhou Tongda Auto Electric Co.Ltd(603390) , Weihai Guangtai Airport Equipment Co.Ltd(002111) , Jiangsu Jingxue Insulation Technology Co.Ltd(301010) and other companies responded to the situation of relevant businesses. Most companies said that the business revenue accounted for a small proportion of revenue.
The reporter of the Securities Times noted that at present, the prices of nucleic acid detection kiosks in the market are different. According to the public bidding information, the average price ranges from 20000 yuan to 50000 yuan, and there are no unified regulations on the configuration of products. However, from the perspective of market expectation, the coupon business opportunity agency said that the market space corresponding to mobile nucleic acid sampling equipment exceeds 10 billion, and the procurement of relevant equipment is expected to accelerate the configuration.
increased demand
On May 9, in the teleconference held by the joint prevention and control mechanism of the State Council, it was proposed that “we should improve the sensitivity of monitoring and early warning, and establish a ‘sampling circle’ in big cities within 15 minutes of walking”. Before that, normalization measures have been introduced in Beijing, Shanghai, Wuhan, Hangzhou, Guangzhou, Shenzhen and other places, requiring 2-7 days of negative nucleic acid test certificates to enter and leave public places and take public transport.
It is understood that at present, there are many urban layout kiosks. More than 9900 nucleic acid sampling points have been set up in Shanghai, of which more than 5700 points have been opened for operation, and the nucleic acid detection capacity has reached more than 8 million tubes per day. After the dynamic clearing of social aspects in Shenzhen, nucleic acid detection has become a routine measure, and one convenient nucleic acid sampling point is set for every 30000 people. In addition, Nanjing, Chengdu and other places have also begun to promote the setting of nucleic acid detection kiosks.
According to the reporter, mobile nucleic acid detection equipment is not a new thing, and manufacturers have been engaged in production in the past two years. Since this year, the demand for mobile nucleic acid detection kiosks and other products has increased rapidly.
A manufacturer engaged in the production of nucleic acid sampling kiosks in Qingdao, Shandong Province, said that the company has started to develop and design nucleic acid sampling kiosks since the outbreak of covid-19 pneumonia. Since this year, the demand for orders has increased, with more than 100 sets of orders per day. In addition, a testing company in Jinan also said that the demand for nucleic acid testing vehicles has increased. Since the Spring Festival this year, the company has worked overtime to produce nucleic acid testing vehicles (mobile shelter). At present, it has been sold to more than 10 provinces such as Anhui, Fujian, Gansu and Guangdong. Last year, the total sales of nucleic acid testing vehicles independently developed by it exceeded 400.
revenue accounts for a relatively low proportion
In terms of a shares, many companies have publicly indicated that they have nucleic acid sampling point business.
Weihai Guangtai Airport Equipment Co.Ltd(002111) said at the performance presentation on May 13 that the current market demand for mobile medical equipment is strong, and the company’s orders for mobile medical equipment, including testing equipment, have increased significantly year-on-year. At present, the company is making every effort to speed up the production of mobile medical equipment. At the same time, the company also pointed out that due to the small absolute value of the revenue of the mobile medical equipment sector, the revenue of this sector is only listed in the “other” category in the 2021 annual report. At present, the mobile medical equipment sector will not have a significant impact on the overall revenue of the company.
Beijing Transtrue Technology Inc(002771) said in the announcement of share price changes that the company recently signed the product purchase and sales contract with the center for Disease Control and prevention in Pudong New Area of Shanghai to undertake the construction of some nucleic acid sampling workstations. It is expected that the operating revenue recognized in this order will account for about 3% ~ 5% of the company’s operating revenue in 2022, which is relatively small and will not have a significant impact on the company’s performance.
Guangzhou Tongda Auto Electric Co.Ltd(603390) 5 on May 13, in the announcement of stock price changes, it was stated that the number of nucleic acid sampling vehicles currently in use was no more than 10, which were mainly used to support the epidemic prevention work in Guangzhou and surrounding areas, but had not been carried out nationwide, and the impact of the product on the company’s operating revenue and net profit was negligible.
Jiangsu Jingxue Insulation Technology Co.Ltd(301010) replied on the interactive e-mail that the company currently has a nucleic acid sampling workstation and orders are being delivered in succession; It can be supplied all over the country. At present, those supplied to Shanghai, Beijing, Chongqing and other places have been put into use.
In addition, Pony Testing International Group Co.Ltd(300887) said that the company has successively put nucleic acid detection kiosks in cities where 14 laboratories have been approved for nucleic acid detection of novel coronavirus Shenzhen Leaguer Co.Ltd(002243) said that liheyunji products have been applied to the new mobile intelligent nucleic acid sampling kiosk developed by Shenzhen general hospital on a pilot basis Aucma Co.Ltd(600336) said that the business income of the company accounted for a small proportion of the company’s operating income Hongbaoli Group Corporation Ltd(002165) , Changzhou Tiansheng New Materials Co.Ltd(300169) and other companies also responded one after another.
In terms of share price, the nucleic acid sampling Pavilion sector rose rapidly on May 12 and 13, with an increase of more than 20% in the two days, including Jiangsu Jingxue Insulation Technology Co.Ltd(301010) , Guangzhou Tongda Auto Electric Co.Ltd(603390) , Weihai Guangtai Airport Equipment Co.Ltd(002111) , Beijing Transtrue Technology Inc(002771) and other continuous limits. However, after the fermentation over the weekend, after the opening of this week, the sector fell rapidly, and the share prices of many of the above-mentioned companies also fell.
Insiders pointed out that with the normalization of nucleic acid detection, it seems that the construction of nucleic acid sampling kiosks can bring short-term benefits, but the actual profit contribution is relatively limited. Investors should pay attention to the risk of market speculation, pay attention to the bid winning situation of the company’s business, and whether the relevant business can really bring substantial profit expectations to the listed company in the future.
market space geometry
For the market space of mobile nucleic acid detection, a number of securities companies have also calculated.
Ma Shuai of Anxin securities predicts that if China fully implements the normalization of nucleic acid detection, the monthly detection volume will reach 4.9 billion ~ 6.86 billion people, and the corresponding market space will be 12.25 billion ~ 17.15 billion yuan.
It is worth mentioning that while the demand is growing rapidly, there is still some room for differences in the market quotation of nucleic acid detection kiosks. Public information shows that the government bidding purchase price of nucleic acid detection kiosks in various places ranges from 20000 yuan to 50000 yuan Soochow Securities Co.Ltd(601555) it is estimated that the cost of purchasing sampling points in the first and second tier cities in China is about 4.75 billion yuan.
In addition, mobile nucleic acid sampling kiosks involve multiple upstream links Zheshang Securities Co.Ltd(601878) believes that after the normalization of nucleic acid testing, there are mainly three types of relevant benefit areas, including the setting of sampling points and corresponding infrastructure construction, the demand for instruments and equipment brought by the third-party testing laboratory (ICL) and additional production capacity, nucleic acid testing reagents and consumables, etc. Guosheng securities also believes that normalized nucleic acid detection is expected to lengthen the time of covid-19 business thickening the income of ICL enterprises and benefit the leading ICL service providers with significant scale effect.
